Indonesia vs Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD): Prevalence of current tobacco use

Indonesia
31.0%
in 2024
Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)
19.3%
in 2024
Indonesia rank
26th
Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) rank
29th

Prevalence of current tobacco use over time

  • Indonesia
  • Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)
0102030200020122024

How they compare

Indonesia currently reports 31.0% against 19.3% in Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD), a difference of 11.7%.

That makes Indonesia's figure about 1.6 times Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)'s.

Across all 9 years both countries report, Indonesia has been ahead every year.

Indonesia ranks 26th and Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) ranks 29th of 166 countries.

Indonesia has averaged higher in every one of the 3 decades both report.

Head to head by decade

Decade Indonesia Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) Difference Ahead
2000s 33.9% 26.4% 7.6% Indonesia
2010s 32.4% 22.6% 9.8% Indonesia
2020s 31.2% 19.7% 11.5% Indonesia

Averages of every year both report within each decade.

Frequently asked questions

Which has higher prevalence of current tobacco use, Indonesia or Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)?
Indonesia, at 31.0% against 19.3% in Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) as of 2024.
What is the difference in prevalence of current tobacco use between Indonesia and Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)?
11.7%, with Indonesia ahead.
How many years of comparable data are there for Indonesia and Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)?
9 years are reported by both, from 2000 to 2024.
How do Indonesia and Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) rank globally for prevalence of current tobacco use?
Indonesia ranks 26th and Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) ranks 29th of 166 countries.
Where does this data come from?
Global Health Observatory Data Repository, World Health Organization (WHO), published as Prevalence of current tobacco use (% of adults). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Indonesia vs Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD): Prevalence of current tobacco use. Statizoid, drawing on Global Health Observatory Data Repository, World Health Organization (WHO). Retrieved 18 September 2026, from https://health.statizoid.com/compare/prevalence-of-current-tobacco-use-percent-of-adults/indonesia/middle-east-north-africa-afghanistan-and-pakistan-ida-and-ibrd/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://health.statizoid.com/compare/prevalence-of-current-tobacco-use-percent-of-adults/indonesia/middle-east-north-africa-afghanistan-and-pakistan-ida-and-ibrd/">Indonesia vs Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD): Prevalence of current tobacco use</a> — Statizoid

About this data

Indicator
Prevalence of current tobacco use (% of adults)
Unit
% of adults
Source
Global Health Observatory Data Repository, World Health Organization (WHO)
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
212 places, 1,908 data points, 2000–2024
Last refreshed

The percentage of the population ages 15 years and over who currently use any tobacco product (smoked and/or smokeless tobacco) on a daily or non-daily basis. Tobacco products include cigarettes, pipes, cigars, cigarillos, waterpipes (hookah, shisha), bidis, kretek, heated tobacco products, and all forms of smokeless (oral and nasal) tobacco. Tobacco products exclude e-cigarettes (which do not contain tobacco), “e-cigars”, “e-hookahs”, JUUL and “e-pipes”. The rates are age-standardized to the WHO Standard Population.